Recent patents relating to diagnostic advances in age related macular degeneration (AMD)

Recent Patents on DNA and Gene Sequences

Volumn 3, Issue 2, 2009, Pages 102-113

  Cantsilieris, Stuart ^a,b   Schache, Maria ^a   Ashdown, M Luisa ^b   Baird, Paul N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Genetic Technologies Limited   (Australia)

Author keywords

Age related macular degeneration; Biomarkers; Complement factor h; Copy number variation; Diagnostic; Genetic markers; Single nucleotide polymorphism

Indexed keywords

ABC TRANSPORTER; ATP BINDING CASSETTE TRANSPORTER 4; AUTOANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBOXYETHYLPYRROLE ADDUCT; CHEMOKINE RECEPTOR CCR2; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED 1; COMPLEMENT FACTOR H RELATED 3; COPPER ZINC SUPEROXIDE DISMUTASE; CYSTATIN C; FIBULIN 5; GENE PRODUCT; INTERLEUKIN 1ALPHA; PLATELET DERIVED GROWTH FACTOR C; PROTEIN HTRA1; PROTEIN PLEKHA1; RETINA PIGMENT EPITHELIAL PROTEIN 65; SOMATOMEDIN; SYNAPTOPORIN; TRANSFERRIN; UNCLASSIFIED DRUG; COMPLEMENT FACTOR H, HUMAN;

ABDOMINAL AORTA ANEURYSM; ANTIBODY DETECTION; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; CARDIOVASCULAR DISEASE; CHROMOSOME 10Q; CHRONIC INFLAMMATION; COMPLEMENT ACTIVATION; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; DRUSEN; GENE CLUSTER; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE NUMBER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INFLAMMATION; MACROPHAGE; OXIDATIVE STRESS; PATENT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STARGARDT DISEASE; CHROMOSOME 10; GENETICS; RETINA MACULA DEGENERATION;

BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, PAIR 10; COMPLEMENT FACTOR H; HUMANS; MACULAR DEGENERATION; PATENTS AS TOPIC;

EID: 70349242069     PISSN: 18722156     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221509788654179     Document Type: Review

References (87)

1. Lotery A, Trump D. Progress in defining the molecular biology of age related macular degeneration. Human Genetic 2007; 122: 219-236.
2. Patel N, Adewoyin T, and Chong NV.Age-related macular degeneration:A perspective on genetic studies. Eye 2007; 1-9.
3. Paul NB, Amirul Islam FM, Richardson AJ, et al. Analysis of the Y402H Variant of the complement factor h gene in age-related macular degeneration. Investigative Ophthalmology and Visual Sci 2006; 47: 4194-4198.
4. Cook HL, Patel PJ, Tufail A. Age-related macular degeneration: Diagnosis and management. British Medical Bullitin 2008; 85: 127-149.
5. Paul NB, Guida E, Chu DT, Vu HTV, Guymer RH. The e2 and e4 Alleles of the Apolipoprotein gene are associated with age-related macular degeneration. Investigative Ophthalmol Visual Sci 2004; 45: 1311-1315.
6. Schmidt S, Haines JL, Postel EA, et al. Joint effects of smoking history and APOE genotypes in age-related macular degeneration. Mol Vision 2005; 11: 941-949.
7. Montezuma SR, Sobrin L, Seddon JM. Review of genetics in age related macular degeneration. Seminars in Ophthalmol 2007; 22: 229-240.
8. Baird PN, Richardson AJ, Robman LD, et al. Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration. Human Mutation 2006; 27: 337-342.
9. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmol 2001; 108: 697-704.
10. Haines JL, HauserMA, Schmidt S, et al. Complement factor h variant increases the risk of age-related macular degeneration. Sci 2005; 308: 419-421.
11. Swaroop A, Branham KE, Chen W, Abecasis G. Genetic susceptibility to age-related macular degeneration: A paradigm for dissecting complex disease traits. Human Molecul Geneti 2007; 16: 174-182.
12. Rivera A, Fisher SA, Fritsche LG, et al. Weber. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Human Molec Geneti 2005; 14: 3227-3236.
13. Hageman SG, Anderson DH, Johnson LV,et al. A common haplotype in the complement gene factor regulatory H (HF1/CFH) predisposes individuals to are related macular degeneration. Proceed National Acad Sci 2005; 102: 7227-7232.
14. Edwards AO, Ritter III R, Abel KJ, et al. Complement factor h polymorphism and age-related macular degeneration. Sci 2005; 308: 421-423.
15. Klein RJ, Zeiss C, Chew EY, et al. Complement factor h polymorphism in age-related macular degeneration. Sci 2005; 308: 385-389.
16. Seddon JM, Francis PJ, George S, et al. Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. Journal of the American Medical Associat 2008; 297: 1793-1800. (Pubitemid 46658648)
17. Ogata T, Shibamura H, Tromp G, et al. Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. Journal of Vascul Surg 2005; 41: 1036-1042. (Pubitemid 40813036)
18. Wanhainen A, Bergqvist D, Boman K, et al. Risk factors associated with abdominal aortic aneurysm: A population-based study with historical and current data. Journal of Vascul Surg 2005; 41: 390-396. (Pubitemid 40523577)
19. Robman ML, McNeil J, Dimitrov P, et al. Methodology of the cardiovascular health and age-related maculopathy (CHARM) study. Ophthalmic Epidemiol 2004; 11: 161-179. (Pubitemid 39369427)
20. Robman L, McNeil J, Dimitrov P, et al. Methodology of the cardiovascular health and age-related maculopathy (CHARM) study. Ophthalmic Epidemiol 2004; 11: 161-179. (Pubitemid 39369427)
21. Klein R, Klein BEK, Knudston MD, et al. Subclinical atherosclerotic cardiovascular disease and early age-related macular degeneration in a multiracial cohort. Archives of Ophthalmol 2007; 125: 534-543.
22. Gregory, S.H., Robert, F.M., US20007108982 (2000).
23. Seddon JM, Gensler G, Milton RC, Michael L. Klein, Nadar Rifai. Association between c-reactive protein and age-related macular degeneration. Americ Medi Associat 2004; 291: 704-710.
24. Seddon JM, George S, Rosner B, Nader Rifai. Progression of age-related macular degeneration: prospective assessment of c-reactive protein, Interleukin 6, and other cardiovascular biomarkers. Archi Ophtha 2005; 123: 774-782. (Pubitemid 41056598)
25. Mullins RF, Russell SR, Anderson DH,. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB 2000; 14: 835-846.
26. Johanna, S.: WO2005083430(2005).
27. Johanna, S.: WO2005084188 (2005).
28. Anderson DH, Mullins RF, Hageman GS, et al. A role for local inflammation in the formation of drusen in the aging eye. Americ Ophthal 2002; 134: 411-431.
29. Johnson, Lincoln V, A potential role for immune complex pathogenesis in drusen formation. Experimental Eye Resea 2000; 70: 441-449.
30. Hageman GS, Luthert PJ, Victor CNH, et al. An Integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the rpe-bruch's membrane interface in aging and age-related macular degeneration. Progress in Retina Eye Resea 2001; 20: 705-732.
31. Gregory, S., Hageman, R. M. US20067011952 (2006)
32. Gregory, S., Hageman, R. M. US20037351524 (2003).
33. Johnson PT, Betts KE, Radeke MJ, et al. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proce National Acad Sci 2006; 103: 17456-17461.
34. Gregory, S., Hageman, S. M., WO2007118095 (2007).
35. Gu X, Meer SG, Miyagi M, et al. Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. Biologi Chem 2003; 278: 42027-42035. (Pubitemid 37310467)
36. Joe, C. H., Robert, G., Salomon, W., Crabb, X.G. US20080160505 (2008).
37. Gregory, S.H., Richard, J.S. US20070020647 (2007).
38. Margaret, A., Pericak-Vance, J., H. WO 2006096561 (2006)
39. Lindsay, F., Albert, O., E. WO2006096737 (2006).
40. Josephine, H., Robert, J.K. US20090017029 (2009).
41. Gold B, Merriam JE, Zernant J, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nature Geneti 2006; 38: 458-462.
42. Michael, C., Dean. A., G., Rando, L., Allikmets, H. WO2007120975 (2007).
43. Julian BM, Jesen AF, Robyn CR, et al. Variation in complement factor 3 is associated with risk of agerelated macular degeneration. Nature Geneti 2007; 39: 1200.
44. Johanna, S. WO2008140793 (2008).
45. john rw, yates, tiina s, et al. complement c3 variant and the risk of age-related macular degeneration. Medic 2007; 357: 553-561. (Pubitemid 47236280)
46. Andrew D, Mugen L, Stephen H,et al. HTRA1 Promoter Polymorphism in Wet Age-related macular degeneration. Sci 2006; 314: 989-992. (Pubitemid 44749943)
47. Johanna J, Yvette PC, Daniel EW, Tammy S, Michael G, Robert E. Susceptibility genes for age-related maculopathy on chromosome 10q26. Americ Human Genet 2005; 77: 389-407.
48. Leveziel N, Souied EH, Richard F, et al. PLEKHA1-LOC387715-HTRA1 polymorphisms and exudative age-related macular degeneration in the French population. Mole Visi 2007; 13: 2153-2159.
49. Shannon KJ, Schmidt S, Agarwal A, et al. Haines linkage analysis for age related macular degeneration supports a gene on chromosome 10q26. Mole Vis 2004; 10: 57-61.
50. Weger M, Renner W, Steinbrugger I, et al. Association of the HTRA1 -625G>A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mole Visi 2007; 13: 1274-1279.
51. Francis PJ, Zhang H, Wan AD, Hoh J, Klein M. Joint effects of polymorphisms in the HTRA1, LOC387715/ARMS2, and the CFH genes on AMD in Caucasian population. Mole Vis 2008; 14: 1395-1400.
52. Michael, B.G., Daniel, E.W., Yvette P.C., Robert,F., Johanna, J., Tammy, S.M.-.Fr,
53. WO2006133295 (2006).
54. Josephine Hoh, Andrew Dewan, WO 2008/013893 A2, (2008)
55. Kang, Z., WO2008112801 (2008).
56. Yang Z, Camp NJ, Sun H, et al. A Variant of the htra1 gene increases susceptibility to age-related macular degeneration. Sci 2006; 314: 992-993.
57. DeAngelis MM, Ji F, Adams S, et al. Alleles in the HtrA Serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. Ameri Acad Ophthal 2007; 115: 1209-1215.
58. Margaret, M., DeAngelis. US 20080206263 (2008).
59. Josephine, H., WO2007044897 (2007).
60. Fisher SA, Abecasis GR, Yashar BM, et al. Meta-analysis of genome scansof age-related macular degeneration. Human Mol Genet 2005; 14: 2257-2264.
61. Ambati J, Anand A, Fernandez S, et al. An animal model of age related macular degeneration in senescent Ccl-2 or Ccr-2 deficient mice. Nature Medi 2003; 9: 1390-1397. (Pubitemid 37466188)
62. Chan CC, Ross RJ, Shen D, et al. Ccl2/Cx3cr1 Deficient Mice: An animal model for age related macular degeneration. Ophthal Resear 2008; 40: 124-128.
63. Bendik I, Sancak O, Schalch W, et al. Comprehensive analysis of the candidate genes CCL2, CCR2 and TLR4 in age related macular degeneration. Invest Ophthalmol Vis Sci 2008; 49: 364-371.
64. Jayakrishna, A. US2004/0177387(2004).
65. Igor, B., Ozgur, S., Wolfgang, S., Jonas, W.: WO2008110824 (2008).
66. Scholl HPN, Fleckenstein M, Issa PC, et al. An update on the genetics of age-related macular degeneration. Moler Visi 2007; 13: 196-205.
67. Bernstein PS, Leppert M, Singh N, et al. Genotype-Phenotype Analysis of ABCR Variants in Macular Degeneration Probands and Siblings. Investi Ophthal Visual Sci 2002; 43: 466-473.
68. WebsteAR, Heon E, Lotery AJ, et al. An analysis of allelic variation in the abca4 gene. Investiga Ophthal Visual Sci 2001; 42: 1179-1189.
69. Guymer RH, Heon E, Lotery AJ, et al. Variation of Codons 1961 and 2177 of the Stargardt Disease Gene Is Not Associated With Age-Related Macular Degeneration. Arch Ophthalmology, 2001; 119: 745-751.
70. Zurdel J, Finckh U, Menzer G, Nitsch RM, Richard G. CST3 genotype associated with exudative age related macular degeneration. British Ophthalmol 2002; 86: 214-219.
71. Giesbert, R., Roger, N. US20070117122 (2007).
72. Edwin, S. US20060024688 (2006).
73. Stone EM, Lotery AJ, Munier FR, et al. A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nature Geneti 1999; 22: 199-202.
74. Stone EM,.Braun TA, Russell SR, et al. Variations in the Fibulin 5 Gene and Age-Related Macular Degeneration. Medic 2004; 351: 346-353.
75. Winkler BS, Boulton ME, Gottsch JD, et al. Oxidative damage and age-related macular degeneration. Molec Vision 1999; 5:
76. Dong A, Xie B, Shen J, et al. Oxidative stress promotes ocular neovascularization. Cellular Physiology 2009; 219: 544-552.
77. Imamura Y, Noda S, Hashizume K, et al. Choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: A model of age-related macular degeneration. Proceedi National Acade Sci 2006; 103: 11282-11287.
78. Yoshida S, Yashar BM, Hiriyanna S. Microarray analysis of gene expression in the aging human retina. Investiga Ophthalmo Visual Sci 2002; 43: 2554-2560.
79. Haines JL, Schnetz-Boutaud N, Schmidt S, et al. Functional Candidate Genes in Age-Related Macular Degeneration: Significant Association with VEGF, VLDLR, and LRP6. Investigative Ophthalmol Visual Sci 2006; 47: 329-335. (Pubitemid 46780832)
80. Hahn P, Milam AH, Dunaief JL. Maculas affected by age-related macular degeneration contain increased chelatable iron in the retinal pigment epithelium and Bruch's membrane. Archives of Ophthalmol 2003; 121: 1099-1105.
81. Chowers I, Wong R, Dentchev T, et al. The Iron Carrier Transferrin Is Upregulated in Retinas from Patients with Age-Related Macular Degeneration. Investiga Ophthalmol Visual Sci 2006; 47: 2135-2140.
82. Simons K, Artificial l. Early-life exposure in age-related macular degeneration and in cataractogenic phototoxicity. Archi Ophthalmol 1993; 111: 297-298.
83. Grimm C, Wenzel A, Hafezi F, Yu ST. et al. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nature Geneti 2000; 25: 63-66.
84. Hughes AE, Orr N, Esfandiary H, et al. A common CFH haplotype, with deletion of CFHR1 andCFHR3, is associated with lower risk of age-related macular degeneration. Nature Genet 2006; 38: 1173-1777.
85. Hageman GS, Hancox LS, Taiber AJ, et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications. Annal Medi 2006; 38: 592-604.
86. Spencer KL, Hauser MA, Olson LM, et al. Deletion of CFHR3 and CFHR1 genes in age-related macular degeneration. Human Mole Geneti 2008; 17: 971-977.
87. Gregory, S., Hageman, WO2008008986 (2008).